Lucentis 50242-0082-03
Generic: Ranibizumab
- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravitreal
- Product Type
- Human Prescription Drug
- Marketing Start
- August 10, 2012
- Listing Expires
- December 31, 2026
- Application
- BLA125156
Need to source Lucentis? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranibizumab | 6 mg/mL |
Drug Class
Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitors [MoA]
Selected Package
50242-0082-03Selected1 SYRINGE, GLASS in 1 CARTON (50242-082-03) / .05 mL in 1 SYRINGE, GLASS
Other packages for this product(1)
1 SYRINGE, GLASS in 1 CARTON (50242-082-88) / .05 mL in 1 SYRINGE, GLASS